Gover Ayala, Smolkin Tatiana, Molad Michal, Lavie-Nevo Karen, Iofe Adir, Zoabi-Safadi Rasha, Toropine Arina, Saab Rawnak Nazem, Waisman Dan, Rotschild Avi, Kugelman Amir, Riskin Arieh
Neonatal Intensive Care Unit, Bnai-Zion Medical Center, Haifa, Israel.
Ruth and Bruce Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.
Pediatr Pulmonol. 2025 Jun;60(6):e71167. doi: 10.1002/ppul.71167.
Heated humidified high flow (HHHFNC) and nasal intermittent positive pressure ventilation (NIPPV) delivered by cannula with long and narrow tubing (CLNT) are increasingly used in preterm infants for providing noninvasive respiratory support, due to their high comfort level and minimal nasal trauma. Despite their widespread use, no randomized controlled trial has been conducted so far.
Determine whether HHHFNC is non-inferior to CLNT-NIPPV in providing respiratory support for preterm infants.
An unblinded, randomized controlled, non-inferiority multicenter trial.
Preterm infants randomized to either HHHFNC or CLNT-NIPPV. Infants born > 28 weeks of gestation were eligible to enter the study either as primary treatment after birth or post-extubation. Infants born ≤ 28 weeks of gestation were only eligible post-extubation. The primary outcome was treatment failure within 7 days.
One hundred and thirty infants were enrolled in the study; 65 in each group. Most (82%) were > 28 weeks, and primary treatment (73%). HHHFNC was non-inferior to CLNT-NIPPV in the primary outcome which occurred in 12.3% compared to 23.0% of the infants, respectively (risk difference (RD) -10.77%, 95% CI of RD -23.7 to 2.22 [within the non-inferiority margin], χp = 0.168). HHHFNC was associated with significantly less nasal trauma compared to CLNT-NIPPV but with longer time on the allocated respiratory support. No significant differences were found between the groups in secondary respiratory and neonatal outcomes.
In this study of preterm infants mostly > 28 weeks of gestation, HHHFNC was non-inferior to CLNT-NIPPV in providing respiratory support, and caused less nasal trauma.
温热湿化高流量鼻导管通气(HHHFNC)和通过长而窄的管道(CLNT)进行的鼻间歇正压通气(NIPPV)因其舒适性高和鼻创伤小,越来越多地用于为早产儿提供无创呼吸支持。尽管它们已被广泛使用,但迄今为止尚未进行随机对照试验。
确定HHHFNC在为早产儿提供呼吸支持方面是否不劣于CLNT-NIPPV。
一项非盲、随机对照、非劣效性多中心试验。
将早产儿随机分为HHHFNC组或CLNT-NIPPV组。孕龄>28周的婴儿在出生后作为主要治疗或拔管后符合纳入研究的条件。孕龄≤28周的婴儿仅在拔管后符合条件。主要结局是7天内治疗失败。
130名婴儿纳入研究;每组65名。大多数(82%)孕龄>28周,且为主要治疗(73%)。在主要结局方面,HHHFNC不劣于CLNT-NIPPV,分别有12.3%和23.0%的婴儿出现该结局(风险差异(RD)-10.77%,RD的95%置信区间为-23.7至2.22[在非劣效界值内],χp = 0.168)。与CLNT-NIPPV相比,HHHFNC导致的鼻创伤明显更少,但接受分配的呼吸支持的时间更长。两组在次要呼吸和新生儿结局方面未发现显著差异。
在这项主要针对孕龄>28周的早产儿的研究中,HHHFNC在提供呼吸支持方面不劣于CLNT-NIPPV,且导致的鼻创伤更小。